Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for P28824
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-P28824-F1 | Predicted | AlphaFoldDB |
No variants for P28824
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for P28824 | |||||
No associated diseases with P28824
6 regional properties for P28824
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Coagulation factor 5/8 C-terminal domain | 274 - 424 | IPR000421-1 |
| domain | Coagulation factor 5/8 C-terminal domain | 430 - 584 | IPR000421-2 |
| domain | CUB domain | 27 - 141 | IPR000859-1 |
| domain | CUB domain | 147 - 265 | IPR000859-2 |
| domain | MAM domain | 646 - 812 | IPR000998 |
| domain | Neuropilin, C-terminal | 848 - 927 | IPR022579 |
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| mitochondrial membrane | Either of the lipid bilayers that surround the mitochondrion and form the mitochondrial envelope. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
5 GO annotations of molecular function
| Name | Definition |
|---|---|
| growth factor binding | Binding to a growth factor, proteins or polypeptides that stimulate a cell or organism to grow or proliferate. |
| heparin binding | Binding to heparin, a member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues. |
| metal ion binding | Binding to a metal ion. |
| semaphorin receptor activity | Combining with a semaphorin, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. |
| vascular endothelial growth factor receptor activity | Combining with a vascular endothelial growth factor (VEGF) receptor ligand and transmitting the signal across the plasma membrane to initiate a change in cell activity. |
6 GO annotations of biological process
| Name | Definition |
|---|---|
| angiogenesis | Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. |
| animal organ morphogenesis | Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions. |
| axon guidance | The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues. |
| endothelial cell chemotaxis | The directed movement of an endothelial cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). |
| regulation of plasma membrane bounded cell projection organization | Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of plasma membrane bounded cell projections. |
| vascular endothelial growth factor receptor signaling pathway | The series of molecular signals initiated by a ligand binding to a vascular endothelial growth factor receptor (VEGFR) on the surface of the target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MLLRLLSCCC | WLLCSLRSSW | ASRNDKCGDT | IKITSPSYLT | SAGYPHSYPP | SQRCEWLIQA |
| 70 | 80 | 90 | 100 | 110 | 120 |
| PEHYQRIMIN | FNPHFDLEDR | ECKYDYVEVI | DGDNANGQLL | GKYCGKIAPS | PLVSTGPSIF |
| 130 | 140 | 150 | 160 | 170 | 180 |
| IRFVSDYETP | GAGFSIRYEV | FKTGPECSRN | FTSSNGVIKS | PKYPEKYPNA | LECTYIIFAP |
| 190 | 200 | 210 | 220 | 230 | 240 |
| KMQEIVLEFE | SFELEADSNA | PGGQTCRYDW | LGIWDGFPGV | GPHIGRYCGQ | NTPGRVRSFT |
| 250 | 260 | 270 | 280 | 290 | 300 |
| GILSMIFHTD | SAIAKEGFFA | NFSVVQSNTD | EDFQCKEALG | MESGEIHFDQ | ISVSSQYSMN |
| 310 | 320 | 330 | 340 | 350 | 360 |
| WSAERSRLNY | VENGWTPGED | TVKEWIQVDL | ENLRFVSGIG | TQGAISKETK | KKYFVKSYKV |
| 370 | 380 | 390 | 400 | 410 | 420 |
| DISSNGEDWI | TLKDGNKHLV | FTGNTDATDV | VYRPFSKPVI | TRFVRLRPVT | WENGISLRFE |
| 430 | 440 | 450 | 460 | 470 | 480 |
| LYGCKITDYP | CSRMLGMVSG | LISDSQITAS | SQVDRNWVPE | LARLVTSRSG | WALPPSNTHP |
| 490 | 500 | 510 | 520 | 530 | 540 |
| YTKEWLQIDL | AEEKIVRGVI | IQGGKHKENK | VFMRKFKIGY | SNNGTEWEMI | MDSSKNKPKT |
| 550 | 560 | 570 | 580 | 590 | 600 |
| FEGNTNYDTP | ELRTFAHITT | GFIRIIPERA | SASGLALRLE | LLGCEVETPT | SIPTTPEVNG |
| 610 | 620 | 630 | 640 | 650 | 660 |
| GDECEGDLAN | CHSGTDEGFK | LTVGATGQST | ETPTVEASPE | EPDMTHSDLD | CKFGWGSQKT |
| 670 | 680 | 690 | 700 | 710 | 720 |
| VCNWQHDISS | DLKWAVLNSK | TGPVQDHTGD | GNFIYSEADE | RHEGRAARLM | SPVVSSSRSA |
| 730 | 740 | 750 | 760 | 770 | 780 |
| HCLTFWYHMD | GSHVGTLSIK | LKYEMEEDFD | QTLWTVSGNQ | GDQWKEARVV | LHKTMKQYQV |
| 790 | 800 | 810 | 820 | 830 | 840 |
| IVEGTVGKGS | AGGIAVDDII | IANHISPSQC | RAPEIDDSAN | KIGEEDSEID | KTGSTPNYAL |
| 850 | 860 | 870 | 880 | 890 | 900 |
| NEFNESISKK | PGNVLKTLDP | ILITIIAMSA | LGVLLGAICG | VVLYCACWHN | GMSERNLSAL |
| 910 | 920 | ||||
| ENYNFELVDG | VKLKKDKLNT | QNSYSEAS |